Literature DB >> 24483833

Predictors for thyroid carcinoma in Israel: a national cohort of 1,624,310 adolescents followed for up to 40 years.

Alon Farfel1, Jeremy D Kark, Estela Derazne, Dorit Tzur, Micha Barchana, Liora Lazar, Arnon Afek, Ari Shamiss.   

Abstract

INTRODUCTION: Data on adolescent precursors of thyroid cancer in adulthood are scant.
METHODS: In order to evaluate potential risk factors for thyroid cancer, we linked two national data sources: the military recruitment health examinations and the Israel National Cancer Register. The study population (1,624,310 participants) included 1,145,865 Jewish males aged 16-19 years when examined between 1967 and 2005, and 478,445 Jewish females aged 16-19 years when examined between 1989 and 2005. The cancer follow-up extended up to 2006. Multivariable Cox proportional hazards modeling was used.
RESULTS: During 24,389,502 person years of follow-up, 760 incidence cases of thyroid cancer were identified. The mean age at diagnosis was 25.2±4.2 years for women and 37.2±10.0 years for men. Women had a substantially higher incidence (birth cohort-adjusted hazard ratio (HR)=5.70 [95% CI 4.45-7.31]; p<0.001). Height predicted incidence in both sexes, with birth cohort-adjusted HRs of 1.03 (p<0.001) in males and 1.04 (p<0.001) in females, per 1 cm increment in height. In males, but not in females, there was a graded association between education, as measured by years of schooling, and incidence of thyroid cancer. Body mass index was not associated with incidence. In a multivariable analysis of 617,613 males and 469,185 females examined from 1989 onwards, which included sex, birth year, height, and education, the excess risk in females persisted strongly (HR=5.67 [CI 4.30-7.13]), as did the association with height.
CONCLUSIONS: Female sex, measured height in adolescence, and later birth cohorts were independent predictors of thyroid cancer in young and middle-aged adults in Israel. Further study is needed to unravel the mechanisms whereby height is associated with thyroid cancer.

Entities:  

Mesh:

Year:  2014        PMID: 24483833     DOI: 10.1089/thy.2013.0173

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  6 in total

1.  Correlation between body mass index and clinicopathological features of papillary thyroid microcarcinoma.

Authors:  Zeming Liu; Yusufu Maimaiti; Pan Yu; Yiquan Xiong; Wen Zeng; Xiaoyu Li; Haiping Song; Chong Lu; Yue Xin; Jing Zhou; Ning Zhang; Jie Ming; Chunping Liu; Wei Shi; Lan Shi; Xueqin Li; Xiu Nie; Tao Huang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  Meta-analysis in the association between obesity and risk of thyroid cancer.

Authors:  Wei Zhang; Xiyong Bai; Huai'e Ge; Haibin Cui; Zhijiang Wei; Guoda Han
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 3.  Morbid Obesity and Thyroid Cancer Rate. A Review of Literature.

Authors:  Stefania Masone; Nunzio Velotti; Silvia Savastano; Emanuele Filice; Rossana Serao; Antonio Vitiello; Giovanna Berardi; Vincenzo Schiavone; Mario Musella
Journal:  J Clin Med       Date:  2021-04-27       Impact factor: 4.241

4.  Obesity and risk of thyroid cancer: evidence from a meta-analysis of 21 observational studies.

Authors:  Jie Ma; Min Huang; Li Wang; Wei Ye; Yan Tong; Hanmin Wang
Journal:  Med Sci Monit       Date:  2015-01-22

5.  Risk of thyroid cancer in relation to height, weight, and body mass index in Japanese individuals: a population-based cohort study.

Authors:  Junya Sado; Tetsuhisa Kitamura; Tomotaka Sobue; Norie Sawada; Motoki Iwasaki; Shizuka Sasazuki; Taiki Yamaji; Taichi Shimazu; Shoichiro Tsugane
Journal:  Cancer Med       Date:  2018-03-25       Impact factor: 4.452

6.  The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer.

Authors:  Danuta Gąsior-Perczak; Iwona Pałyga; Monika Szymonek; Artur Kowalik; Agnieszka Walczyk; Janusz Kopczyński; Katarzyna Lizis-Kolus; Tomasz Trybek; Estera Mikina; Dorota Szyska-Skrobot; Klaudia Gadawska-Juszczyk; Stefan Hurej; Artur Szczodry; Anna Słuszniak; Janusz Słuszniak; Ryszard Mężyk; Stanisław Góźdź; Aldona Kowalska
Journal:  PLoS One       Date:  2018-10-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.